- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02158325
Capsulorhexis Size and Capsular Outcome
June 6, 2014 updated by: Haotian Lin, Sun Yat-sen University
Appropriate Capsulorhexis Size Results in Better Capsular Outcome When Treating Pediatric Cataract: A Randomized Controlled Trial
Different capsulorhexis size results in different capsular outcome when treating pediatric cataract, and there should be an appropriate capsulorhexis size for the best capsular outcome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Numerous studies have reported that ideal anterior capsulorhexis size is 4.5-5.0
mm with the capsulorhexis edges covering IOL optic surface because it can inhibit the proliferation and migration of remnant lens epithelial cells (LEC).
But there are no reports investigating the relationship between the capsulorhexis size and the capsular outcome after pediatric cataract surgery.
Therefore, the aim of the current study is to prospective evaluate the capsular outcomes of three controlled groups receiving different anterior capsulorhexis sizes (3.0-3.9, 4.0-5.0,
5.1-6.0 mm in diameter).
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Zhongshan Ophthalmic Center,Sun Yat-Sen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 2 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age< 2 years
- performed cataract surgery without IOL implantation
- without capsular fibrosis, glaucoma, ocular trauma, corneal disorders before surgery
- No other corneal and systemic abnormalities
- Written informed consents provided
Exclusion Criteria:
- Patients with glaucoma, ocular trauma, corneal disorders, persistent hyperplastic primary vitreous, rubella, Lowe syndrome, capsular fibrosis
- Cases with surgical complications
- those who can't dilute pupil normally postoperation or can't complete the follow-up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 3.0-3.9 mm
pediatric cataract surgery performed with different anterior capsulorhexis sizes (3.0-3.9 mm in diameter)
|
Pediatric cataract surgery performed with different anterior capsulorhexis sizes (3.0~3.9, 4.0~5.0,
5.1~6.0 mm in diameter)
|
Experimental: 4.0-5.0 mm
pediatric cataract surgery performed with different anterior capsulorhexis sizes (4.0-5.0 mm in diameter)
|
Pediatric cataract surgery performed with different anterior capsulorhexis sizes (3.0~3.9, 4.0~5.0,
5.1~6.0 mm in diameter)
|
Active Comparator: 5.1-6.0 mm
pediatric cataract surgery performed with different anterior capsulorhexis sizes (5.1-6.0 mm in diameter)
|
Pediatric cataract surgery performed with different anterior capsulorhexis sizes (3.0~3.9, 4.0~5.0,
5.1~6.0 mm in diameter)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Mean area of anterior/posterior capsulorhexis opening
Time Frame: two years
|
two years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the ratio of opacity accounting for posterior capsulorhexis opening at different visits
Time Frame: two years
|
two years
|
The area change of anterior/posterior capsulorhexis opening
Time Frame: two years
|
two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Lin H, Chen W, Luo L, Congdon N, Zhang X, Zhong X, Liu Z, Chen W, Wu C, Zheng D, Deng D, Ye S, Lin Z, Zou X, Liu Y. Effectiveness of a short message reminder in increasing compliance with pediatric cataract treatment: a randomized trial. Ophthalmology. 2012 Dec;119(12):2463-70. doi: 10.1016/j.ophtha.2012.06.046. Epub 2012 Aug 24.
- Lin H, Chen W, Luo L, Zhang X, Chen J, Lin Z, Qu B, Zhan J, Zheng D, Zhong X, Tian Z, Liu Y; Study Group of CCPMOH. Ocular hypertension after pediatric cataract surgery: baseline characteristics and first-year report. PLoS One. 2013 Jul 29;8(7):e69867. doi: 10.1371/journal.pone.0069867. Print 2013.
- Luo L, Lin H, Chen W, Wang C, Zhang X, Tang X, Liu J, Congdon N, Chen J, Lin Z, Liu Y. In-the-bag intraocular lens placement via secondary capsulorhexis with radiofrequency diathermy in pediatric aphakic eyes. PLoS One. 2013 Apr 24;8(4):e62381. doi: 10.1371/journal.pone.0062381. Print 2013.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
November 1, 2012
Study Completion (Actual)
November 1, 2012
Study Registration Dates
First Submitted
June 4, 2014
First Submitted That Met QC Criteria
June 4, 2014
First Posted (Estimate)
June 6, 2014
Study Record Updates
Last Update Posted (Estimate)
June 9, 2014
Last Update Submitted That Met QC Criteria
June 6, 2014
Last Verified
June 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCPMOH2010-China6
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Cataract
-
Bambino Gesù Hospital and Research InstituteCompletedCataract Congenital
-
Sun Yat-sen UniversityCompletedCongenital Cataract
-
St. Erik Eye HospitalUnknown
-
Sun Yat-sen UniversityMinistry of Health, ChinaCompleted
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Cambridge University Hospitals NHS Foundation TrustNot yet recruitingCongenital Cataract
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityCompleted
-
yin ying zhaoCompletedCongenital CataractChina
-
Wenzhou Medical UniversityCompleted
-
Wenzhou Medical UniversityCompletedCongenital CataractChina
Clinical Trials on anterior capsulorhexis sizes
-
Northwestern UniversityOptiMedica CorporationCompletedCapsulorhexisUnited States
-
Johns Hopkins UniversityVital StrategiesCompletedCardiovascular Diseases | Hypertension | Blood Pressure | Cardiovascular Risk FactorUnited States
-
Minia UniversityCompletedPosterior Capsule OpacificationSaudi Arabia
-
Alcon, a Novartis CompanyCompletedIntumescent Cataract
-
Ziemer Ophthalmic Systems AGCompleted
-
Occlutech International ABCompleted
-
University Hospital, Clermont-FerrandInstitut de Médecine du Travail; UMR CNRS 6024, LaPSCoRecruiting
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Kristiansund HospitalCompletedOsteoarthritis, HipNorway
-
Karolinska InstitutetThe Swedish Society of Medicine; The regional agreement on medical training... and other collaboratorsCompletedVaginal ProlapseSweden, Norway, Denmark, Finland
-
Dow University of Health SciencesCompletedVarying Heights of Power Arm During en Masse RetractionPakistan